A Clinical Study of HX111 in Patients With Advanced Solid Tumor and Lymphoma
Clinical trial NCT07333469 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07333469
- Sponsor
- Hanx Biopharmaceuticals (Wuhan) Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-01-19
- Primary completion
- 2028-01-19
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.